Abstract

Pertussis is a vaccine-preventable disease caused by the bacterium Bordetella pertussis. Over the past years, the incidence and mortality of pertussis increased significantly. A possible cause is the switch from whole-cell to acellular pertussis vaccines, although other factors may also contribute. Here, we applied high-dimensional flow cytometry to investigate changes in B cells in individuals of different ages and distinct priming backgrounds upon administration of an acellular pertussis booster vaccine. Participants were divided over four age cohorts. We compared longitudinal kinetics within each cohort and between the different cohorts. Changes in the B-cell compartment were correlated to numbers of vaccine-specific B- and plasma cells and serum Ig levels. Expansion and maturation of plasma cells 7 days postvaccination was the most prominent cellular change in all age groups and was most pronounced for more mature IgG1+ plasma cells. Plasma cell responses were stronger in individuals primed with whole-cell vaccine than in individuals primed with acellular vaccine. Moreover, IgG1+ and IgA1+ plasma cell expansion correlated with FHA-, Prn-, or PT- specific serum IgG or IgA levels. Our study indicates plasma cells as a potential early cellular marker of an immune response and contributes to understanding differences in immune responses between age groups and primary vaccination backgrounds.

Highlights

  • Pertussis is a vaccine-preventable respiratory disease caused by the bacterium Bordetella pertussis (Bp)

  • We showed that even minor expansions in circulating memory B cells can strongly correlate with a postvaccination increase in Bp-specific serum Ig levels [33]

  • Plasma cell responses were stronger in individuals who were wP-primed

Read more

Summary

Introduction

Pertussis is a vaccine-preventable respiratory disease caused by the bacterium Bordetella pertussis (Bp). Since the introduction of the first pertussis vaccines in the 1940s and. 1950s containing whole inactivated bacteria (whole-cell pertussis; wP), the incidence and mortality of pertussis have dramatically decreased [1]. The wP vaccine itself has a relatively high reactogenicity profile [2,3]. From the early 1980s onwards, many (developed) countries started to replace the wP vaccine by an acellular pertussis (aP)

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.